| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
|
37,145 |
28,924 |
$1.21M |
| 99214 |
|
24,967 |
19,115 |
$1.07M |
| 96372 |
|
13,762 |
9,785 |
$220K |
| 87880 |
|
19,205 |
15,552 |
$216K |
| 99215 |
Prolong outpt/office vis |
2,096 |
1,562 |
$126K |
| 87804 |
|
8,583 |
3,416 |
$97K |
| 96110 |
|
1,375 |
797 |
$42K |
| 90832 |
|
1,384 |
853 |
$32K |
| 80305 |
|
5,080 |
3,821 |
$29K |
| 96127 |
|
4,201 |
1,897 |
$23K |
| 87426 |
|
3,291 |
2,620 |
$19K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
765 |
590 |
$11K |
| 87811 |
|
2,060 |
1,682 |
$11K |
| 99393 |
|
163 |
112 |
$9K |
| 90471 |
|
1,464 |
999 |
$8K |
| 92558 |
|
1,020 |
720 |
$7K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,063 |
3,562 |
$7K |
| 90472 |
|
571 |
378 |
$5K |
| 99177 |
|
792 |
532 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
250 |
214 |
$4K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
495 |
376 |
$4K |
| 99392 |
|
56 |
49 |
$4K |
| 90834 |
|
114 |
88 |
$4K |
| 87635 |
|
68 |
62 |
$3K |
| 99391 |
|
61 |
53 |
$3K |
| 36415 |
|
1,915 |
1,451 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,306 |
1,565 |
$2K |
| 87807 |
|
148 |
122 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
670 |
474 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,845 |
1,935 |
$1K |
| 92552 |
|
72 |
55 |
$778.89 |
| 99173 |
|
167 |
132 |
$766.92 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
247 |
134 |
$757.37 |
| 81003 |
|
503 |
371 |
$691.79 |
| 99204 |
|
21 |
12 |
$682.12 |
| 90791 |
|
12 |
12 |
$583.20 |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
12 |
12 |
$492.00 |
| 96160 |
|
17 |
15 |
$425.25 |
| 3079F |
|
961 |
742 |
$400.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
82 |
58 |
$383.34 |
| 90686 |
|
107 |
83 |
$326.86 |
| 3075F |
|
674 |
525 |
$300.00 |
| 3078F |
|
244 |
181 |
$300.00 |
| 87400 |
|
41 |
35 |
$261.92 |
| 92551 |
|
31 |
26 |
$195.94 |
| 3074F |
|
254 |
171 |
$130.00 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
37 |
31 |
$104.58 |
| 81002 |
|
29 |
27 |
$98.80 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
16 |
13 |
$77.70 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
20 |
15 |
$57.39 |
| 83036 |
|
20 |
16 |
$26.06 |
| 91301 |
|
19 |
16 |
$0.00 |
| 99070 |
|
20 |
13 |
$0.00 |
| 3044F |
|
20 |
16 |
$0.00 |
| 90677 |
|
18 |
12 |
$0.00 |
| 90674 |
|
28 |
13 |
$0.00 |